Skip to main content
SpringerLink
Log in

Debridement

  • Chapter
Wound Healing and Ulcers of the Skin

  • 2203 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown RF: The management of traumatic tissue loss in the lower limb, especially when complicated by skeletal injury. Br J Plast Surg 1965; 18:26–50

    PubMed  Google Scholar 

  2. Monafo WW, Freedman B: Topical therapy for burns. Surg Clin North Am 1987; 67:133–145

    PubMed  Google Scholar 

  3. Witkowski JA, Parish LC: Debridement of cutaneous ulcers: Medical and surgical aspects. Int J Dermatol 1992;9:585–591

    Google Scholar 

  4. Reed BR, Clark RA: Cutaneous tissue repair: Practical implications of current knowledge. J Am Acad Dermatol 1985; 13:919–941

    PubMed  Google Scholar 

  5. Bates-Jansen BM: Management of necrotic tissue. In:Sussman C, Bates-Jensen BM (eds): Wound Care, 1st edn. Gaithersburg: Aspen Publishers. 1998; pp 139–158

    Google Scholar 

  6. Clark RA: Cutaneous tissue repair: Basic biologic considerations. J Am Acad Dermatol 1985; 13:701–725

    PubMed  Google Scholar 

  7. Winter GD: Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193:293–294

    PubMed  Google Scholar 

  8. Steed DL, Donohoe D, Webster MW et al: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996; 183: 61–64

    PubMed  Google Scholar 

  9. Fisher JC: Skin grafting. In: Georgiades GS, Riefkohl R, Levin LS (eds): Plastic, Maxillofacial and Reconstructive Surgery, 3rd edn. Baltimore: Williams & Wilkins 1996; pp 13–18

    Google Scholar 

  10. Marcusson JA, Lindgren C, Berghard A, et al: Allgeneic cultured keratinocytes in the treatment of leg ulcers: A pilot study. Acta Derm Venereol (Stockh) 1992; 72:61–64

    Google Scholar 

  11. Teepe RG, Roseeuw DI, Hermans J, et al: Randomized trial comparing cryopreserved cultured epidermal allgrafts with hydrocolloid dressings in healing chronic venous ulcers. J Am Acad Dermatol 1993; 29: 982–988

    PubMed  Google Scholar 

  12. Pham HT, Rosenblum BI, Lyons TE, et al: Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, ramdomized, dinical trial. Wounds 1999; 11:79–86

    Google Scholar 

  13. Raffetto JD, Mendez MV, Phillips TJ, et al: The effect of passage number on fibroblast cellular senescence in patients with chronic venous insufficiency with and without ulcer. Am J Surg 1999; 178:107–112

    Article  PubMed  Google Scholar 

  14. Mendez MV, Stanley A, Park HY, et al: Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 1998; 28:876–883

    PubMed  Google Scholar 

  15. Agren MS, Steenfos HH, Dabelsteen S, et al: Proliferation and mitogenis response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999; 112: 463–469

    Article  PubMed  Google Scholar 

  16. Feedar JA: Clinical management of chronic wounds. In: McCulloch JM, Kloth LC, Feedar JA (eds): Wound Healing: Alternatives in Management, 2nd edn. Philadelphia. F.A. Davis Company: 1995; pp 137–185

    Google Scholar 

  17. Holm J, Andren B, Grafford K: Pain control in the surgical debridement of leg ulcers by the use of a topical lidocaine-prilocaine cream, Emla. Acta Derm Venereol 1990; 70:132–136

    PubMed  Google Scholar 

  18. Vanscheidt W, Sadjadi Z, Lillieborg S: EMLA anaesthetic cream for sharp leg ulcer debridement: a review of the clinical evidence for analgesic efficacy and tolerability. Eur J Dermatol 2001; 11:90–96

    PubMed  Google Scholar 

  19. Wolff K, Stingl G: Pyoderma gangrenosum. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI and Fitzpatrick TB (eds) Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill. 1999; pp 1140–1148

    Google Scholar 

  20. Schwaegerle SM, Bergfeld WF, Senitzer D, et al: Pyoderma gangrenosum: A review. J Am Acad Dermatol 1988;18:559–568

    PubMed  Google Scholar 

  21. Hopfl R, Hefel L, Fritsch P: Pyoderma gangraenosum: differential diagnosis in ulcus cruris and postoperative exacerbating processes. Wien Med Wochenschr 1994; 144:279–280

    PubMed  Google Scholar 

  22. McCalmont CS, Leshin B, White WL, et al: Vulvar pyoderma gangraenosum. Int J Gynaecol Obstet 1991; 35:175–178

    Article  PubMed  Google Scholar 

  23. Ergun T, Gurbuz O, Harvell J et al: The histopathology of pathergy: a chronologic study of skin hyper-reactivity in Behçet's disease. Int J Dermatol 1998; 37:929–933

    Article  PubMed  Google Scholar 

  24. Gul A, Esin S, Dilsen N, et al: Immunohistology of skin pathergy reaction in Behcet's disease. Br J Dermatol 1995; 132:901–907

    PubMed  Google Scholar 

  25. Gonzales AZ, Gonzales E: Pyoderma gangrenosum: self assessment. J Am Acad Dermatol 1990; 23: 545–548

    Google Scholar 

  26. Odom BO, James WD, Berger TG (eds): Erythema and urticaria. In: Andrews' Diseases of the Skin: Clinical Dermatology, 9th edn. Philadelphia: W.B. Saunders. 2000; pp 146–171

    Google Scholar 

  27. Odom BO, James WD, Berger TG (eds): Disorders of mucous membranes. In: Andrews' Diseases of the Skin: Clinical Dermatology, 9th edn. Philadelphia: W.B. Saunders. 2000; pp 991–1010

    Google Scholar 

  28. Glenchur H, Patel BS, Pathmarajah C: Transient bacteremia associated with debridement of decubitus ulcers. Mil Med 1981; 146:432–433

    PubMed  Google Scholar 

  29. Schmeller W, Gaber Y, Gehl HB: Shave therapy is a simple, effective treatment of persistent venous leg ulcers. J Am Acad Dermatol 1998; 39:232–238

    PubMed  Google Scholar 

  30. Marquez RR: Wound debridement and hydrotherapy. In: Gogia pp (ed): Clinical Wound Management, 1st edn. New Jersey: Slack Incorporated. 1995; pp 115–130

    Google Scholar 

  31. Steve L, Goodhart P, Alexander J: Hydrotherapy burn treatment: Use of chloramine T against resistant microorganisms. Arch Phys Med Rehabil 1979; 60:301–303

    PubMed  Google Scholar 

  32. Thomlinson RH: Kitchen remedy for necrotic malignant breast ulcers. Lancet 1980; 2:707

    Article  PubMed  Google Scholar 

  33. Chirife J, Scarmato G, Herszage L: Scientific basis for the use of granulated sugar in treatment of infected wounds. Lancet 1982; 1:560–561

    Article  PubMed  Google Scholar 

  34. Cooper RA, Molan PC, Harding KG: Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J R Soc Med 1999; 92: 283–285

    PubMed  Google Scholar 

  35. Efem SE: Clinical observations on the wound healing properties of honey. Br J Surg 1988; 75:679–681

    PubMed  Google Scholar 

  36. Zumla A, Lulat A: Honey — a remedy rediscovered. J R Soc Med 1989; 82:384–385

    PubMed  Google Scholar 

  37. Molan PC: Potential of honey in the treatment of wounds and burns. Am J Clin Dermatol 2001; 2: 13–19

    PubMed  Google Scholar 

  38. Sieggreen MY, Maklebust J: Debridement: Choices and challenges. Adv Wound Care 1997; 10:32–37

    Google Scholar 

  39. Rodeheaver GT, Baharestani M, Brabec ME, et al: Wound healing and wound management: Focus on debridement. Adv Wound Care 1994; 7:22–36

    Google Scholar 

  40. Howes EL, Mandl I, Zaffuto S, et al: The use of Clostridium histolyticum enzymes in the treatment of experimental third degree burns. Surg Gynecol Obstet 1959; 109:177–188

    PubMed  Google Scholar 

  41. Boxer AM, Gottesman N, Bernstein H, et al: Debridement of dermal ulcers and decubiti with collagenase. Geriatrics 1969; 24:75–86

    Google Scholar 

  42. Poulsen J, Kristensen VN, Brygger HE, et al: Treatment of infected surgical wounds with varidase. Acta Chir Scand 1983; 149:245–248

    PubMed  Google Scholar 

  43. Hellgren L, Vincent J: Degradation and liquefaction effect of streptokinase-streptodornase and stabilized trypsin on necroses, crusts of fibrinoid, purulent exudate and clotted blood from leg ulcers. J Int Med Res 1977; 5:334–337

    PubMed  Google Scholar 

  44. Hellgren L: Cleansing properties of stabilized trypsin and streptokinase-streptodornase in necrotic leg ulcers. Eur J Clin Pharmacol 1983; 24:623–628

    PubMed  Google Scholar 

  45. Falanga V: Wound bed preparation and the role of enzymes: A case for multiple actions of therapeutic agents. Wounds 2002; 14:47–57

    Google Scholar 

  46. Varma AO, Bugatch E, German FM: Debridement of dermal ulcers with collagenase. Surg Gynecol Obstet 1973; 136:281–282

    PubMed  Google Scholar 

  47. Barrett D Jr, Klibanski A: Collagenase debridement. Am J Nurs 1973; 73:849–851

    PubMed  Google Scholar 

  48. 48. Glyantsev SP, Adamyan AA, Sakharov Y: Crab collagenase in wound debridement. J Wound Care 1997; 6:13–16

    PubMed  Google Scholar 

  49. Westerhof W, Jansen FC, De Wit FS, et al: Controlled double-blind trial of fibrinolysin-desoxyribonu-clease (Elase) solution in patients with chronic leg ulcers who are treated before autologuos skin grafting. J Am Acad Dermatol 1987; 17:32–39

    PubMed  Google Scholar 

  50. Falabella AF, Carson P, Eaglstein WH, et al: The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 1998; 39:737–740

    PubMed  Google Scholar 

  51. Singh GB, Snelling CFT, Hogg GR, et al: Debridement of the burn wound with sutilains ointment. Burns 1979; 7:41–48

    Article  Google Scholar 

  52. Makepeace AR: Enzymatic debridement of burns: a review. Burns Incl Therm Inj 1983; 9:153–157

    PubMed  Google Scholar 

  53. Dimick AR: Experience with the use of proteolytic enzyme (Travase) in burn patients. J Trauma 1977; 17:948–955

    PubMed  Google Scholar 

  54. Berger MM: Enzymatic debriding preparations. Ostomy Wound Manage 1993; 39:61–66

    PubMed  Google Scholar 

  55. Rodeheaver G, Marsh D, Edgerton MT, et al: Proteolytic enzymes as adjuncts to antimicrobial prophylaxis in contaminated wounds. Am J Surg 1975; 129:537–544

    Article  PubMed  Google Scholar 

  56. Alvarez OM, Fernandez-Obregon A, Roisin S, et al: A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement. Wounds 2000; 14:293–301

    Google Scholar 

  57. Silverstein P, Ruzicka FJ, Helmkamp GM, et al: In-vitro evaluation of enzymatic debridement of burn eschar. Surgery 1973; 73:15–22

    PubMed  Google Scholar 

  58. Suomalainen O: Evaluation of two enzyme preparations: Trypure and Varidase in traumatic ulcers. Ann Chir Gynaecol 1983; 72:62–65

    PubMed  Google Scholar 

  59. Nduwimana J, Guenet L, Dorval I, et al: Proteases. Ann Biol Clin 1995; 53:251–264

    Google Scholar 

  60. Westerhof W, Van Ginkel CJ, Cohen EB, et al: Prospective randomized study comparing the debriding effect of Krill enzymes and a non-enzymatic treatment in venous leg ulcers. Dermatologica 1990; 181:293–297

    PubMed  Google Scholar 

  61. Hellgren L, Karlstam B, Mohr V, et al. Krill enzymes. A new concept for efficient debridement of necrotic ulcers. Int J Dermatol 1991; 30:102–103

    PubMed  Google Scholar 

  62. Hellgren L, Vincent J: Debriding properties of krill enzymes in necrotic leg ulcers. Arch Dermatol 1989; 125:1006

    Article  PubMed  Google Scholar 

  63. Kathleen Parfitt (ed) Aserbine. In: Martindale — The Complete Drug Reference, 32nd edn. London: The Pharmaceutical Press. 1999; pp 1678

    Google Scholar 

  64. Madden MR, Finkelstein JL, Hefton JM, et al: Optimal healing of donor site wounds with hydrocolloid dressing. In: Ryan TJ (ed) An Environment for Healing: The Role of Occlusion. London: Royal Society of Medicine. 1985; pp 133–137

    Google Scholar 

  65. Barnett A, Berkowitz, RL, Mills R, et al: Comparison of synthetic adhesive moisture vapor permeable and fine mesh gauze dressings for split-thickness skin graft donor sites. Am J Surg 1983; 145:379–381

    Article  PubMed  Google Scholar 

  66. Mumford JW, Mumford SP: Occlusive hydrocolloid dressings applied to chronic neuropathic ulcers. Int J Dermatol 1988; 27:1900–192

    Google Scholar 

  67. Choucair M, Phillips T: Wound dressing. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill. 1999; pp 2954–2958

    Google Scholar 

  68. Colin D, Kurring PA, Yvon C, et al: Managing sloughy pressure sores. J Wound Care 1996; 5:444–446

    PubMed  Google Scholar 

  69. Flanagan M: The efficacy of a hydrogel in the treatment of wounds with non-viable tissue. J Wound Care 1995; 4:264–267

    PubMed  Google Scholar 

  70. Bale S, Banks V, Haglestein S, et al: A comparison of two amorphous in the debridement of pressure sores. J Wound Care 1998; 7:65–68

    PubMed  Google Scholar 

  71. Rodeheaver GT: Pressure ulcer debridement and cleansing: A review of current literature. Ostomy Wound Management 1999; 45[Suppl 1A]:80S–85S

    Google Scholar 

  72. Mulder GD: Cost-effective managed care: gel versus wet-to-dry for debridement. Ostomy Wound Manage 1995; 41:68–76

    Google Scholar 

  73. Mumcuoglu KY: Clinical applications for maggots in wound care. Am J Clin Dermatol 2001; 2:219–227

    PubMed  Google Scholar 

  74. Bear WS: The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg 1931; 13:438–475

    Google Scholar 

  75. Chernin E: Surgical maggots. South Med J 1986; 79:1143–1145

    PubMed  Google Scholar 

  76. Hewitt F: Osteomyelitis: Development of the use of maggots in treatment. Am J Nurs 1932; 32:31–38

    Google Scholar 

  77. Sherman RA: A new dressing design for use with maggot therapy. Plast Reconstr Surg 1997; 100: 451–456

    PubMed  Google Scholar 

  78. Mumcuoglu KY, Ingber A, Gilead L, et al: Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999; 38:623–627

    Article  PubMed  Google Scholar 

  79. Ziffren SE, Heist HE, May SC, et al: The secretion of collagenase by maggots and its implication. Ann Surg 1953; 138:932–934

    PubMed  Google Scholar 

  80. Robinson W, Norwood VH: Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med 1934; 19:586–581

    Google Scholar 

  81. Robinson W: Stimulation of healing in non-healing wounds by allantoin occurring in maggot secretions and of wide biological distribution. J Bone Joint Surg 1935; 17:267–271

    Google Scholar 

  82. Prete PE: Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanisms of wound healing by maggot therapy. Life Sci 1997; 60:505–510

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). Debridement. In: Wound Healing and Ulcers of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26761-1_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-26761-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21275-1

  • Online ISBN: 978-3-540-26761-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation